An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)
Summary
- Eligibility
- for people ages 3-17 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Neuren Pharmaceuticals Limited
- ID
- NCT05025332
- Phase
- Phase 2 Pitt-Hopkins Syndrome Research Study
- Study Type
- Interventional
- Participants
- Expecting 20 study participants
- Last Updated